Mycoplasma Detection in Biopharmaceuticals

Overview


SGS-WP-Pharma-2016-Mycoplasma-Detection-in-Biopharmaceuticals.jpg

The detection of mycoplasma contamination is of utmost concern in bio-therapeutic and vaccine manufacturing. The two pharmacopeia techniques rely on the agar/broth culture test to detect cultivable mycoplasma, along with the indicator cell culture assay. The main drawback with these protocols is that they take 28 days and about one week to complete respectively. This timescale is problematic for products whose shelf-life is short. For this reason, more rapid alternatives are routinely accepted by the regulators, as long as they are well validated.

This content is provided by SGS Life Science Services, and any views and opinions expressed do not necessarily reflect those of Biopharma-Reporter.com

Download Now


Related Resources

New White Paper: Multiplexing in Bioanalysis

New White Paper: Multiplexing in Bioanalysis

Content provided by SGS Life Science Services

White Paper

SGS scientists have validated a multiplex, bead-based immunoassay which determines nine cytokines simultaneously per sample, resulting in savings in costs, sample volume, and time.  Download this...

Using Multiple Techniques in Protein Characterization

Using Multiple Techniques in Protein Characterization

Content provided by SGS Life Science Services

Case Study

The aggregation of biopharmaceuticals is a complex process, for efficient analysis it’s essential to carefully select orthogonal methods to minimize gaps in the data. This article discusses...

Supplier Info Centre

SGS-SIC-BPR-Pharma-2013.jpg

For more product information visit SGS Life Science Services.